The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Review article: thiopurines in inflammatory bowel disease
Open accessAbstract
Summary: Background: In the past 10–20 years, knowledge of both thiopurine pharmacology and ‐pharmacogenetics has been extended dramatically and used to develop new strategies to improve efficacy and reduce toxicity. Aim: To review thiopurine efficacy, toxicity, pharmacology, pharmacogenetics, interactions in patients with inflammatory bowel disease. Special attention was paid to new strategies for optimization of pharmacotherapy. Methods: To collect relevant scientific articles, a Pubmed search was performed from 1966 through January 2006 with the following key words (MeSH terms preferentially) in multiple combinations: ‘azathioprine’, ‘6‐mercaptopurine’, ‘6‐MP’, ‘6‐thioguanine’, ‘6‐TG’, ‘thiopurine(s)’, ‘metabolites’, ‘level(s)’, ‘TDM’, ‘TMPT’, ‘ITPA’, ‘genotype(s)’, ‘phenotype(s)’, ‘inflammatory bowel disease’, ‘Crohn(’s) disease’, ‘ulcerative colitis’. Results: Strategies for optimization of pharmacotherapy include therapeutic drug monitoring of thiopurine metabolites, geno‐ or phenotyping crucial enzymes in thiopurine metabolism like thiopurine S‐methyltransferase and inosine triphosphate pyrophosphatase, and the use of thioguanine as such. Conclusions: Thiopurine S‐methyltransferase genotyping and therapeutic drug monitoring are useful instruments for individualizing thiopurine pharmacotherapy of inflammatory bowel disease. Inosine triphosphate pyrophosphatase genotyping may be helpful in case of unexplainable myelotoxicity. In case of azathioprine‐ or mercaptopurine‐intolerance, thioguanine seems a promising alternative. However, more knowledge needs to be gathered about its potential hepatotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Cited by
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Gasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., Gomollon, F., Hjortswang, H., Koutroubakis, I., Kulnigg, S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20285 · Cited by 450
Clinical pharmacology and pharmacogenetics of thiopurines
Sahasranaman, S., Howard, D., & Roy, S. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0478-6 · Cited by 405
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
Gisbert, J. P., & Gomolln, F. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01848.x · Cited by 253
Metadata
- Authors
- DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., & HOMMES, D. W.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2006-08-16
- Volume
- 24
- Issue
- 5
- Pages
- 715-729
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2132433180
- Cited by
- 161
- References
- 1
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: thiopurines in inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.02980.x
- The paper
- DERIJKS, L. J. J., GILISSEN, L. P. L., HOOYMANS, P. M., & HOMMES, D. W. (2006). Review article: thiopurines in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.02980.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.